ArticleFrontiers in pharmacology2023

Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model.

Victor Sokolov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.